Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

[An elderly man with known heart failure admitted with cardiogenic shock].

Hovland A, Fagerheim AK, Hardersen R, Nielsen EW.

Tidsskr Nor Laegeforen. 2010 Jul 1;130(13):1352-4. doi: 10.4045/tidsskr.09.0384. Norwegian.

2.
3.

[Hyperkalemia, heart failure and reduced renal function].

Bugge JF.

Tidsskr Nor Laegeforen. 2010 Jul 1;130(13):1354-5. doi: 10.4045/tidsskr.10.0463. Norwegian. No abstract available.

4.
5.

[A patient with severe hyperkalaemia -- an emergency after RALES].

N├╝rnberger J, Daul A, Philipp T.

Dtsch Med Wochenschr. 2005 Sep 9;130(36):2008-11. German.

PMID:
16143930
6.
8.

How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?

Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.

J Card Fail. 2004 Aug;10(4):297-303.

PMID:
15309695
9.
10.

[Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].

Fuster D, Frey FJ, Ferrari P.

Praxis (Bern 1994). 2000 Dec 7;89(49):2073-6. German.

PMID:
11190849
12.

Elderly heart failure patients with drug-induced serious hyperkalemia.

Vanpee D, Swine CH.

Aging (Milano). 2000 Aug;12(4):315-9.

PMID:
11073352
13.

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA.

N Engl J Med. 2004 Aug 5;351(6):543-51.

16.

Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.

Weir MR, Rolfe M.

Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11. Review.

17.

Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.

Tamirisa KP, Aaronson KD, Koelling TM.

Am Heart J. 2004 Dec;148(6):971-8.

PMID:
15632880
18.

Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.

Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS.

Am J Med. 2007 Dec;120(12):1090.e1-8. Review.

PMID:
18060931
19.

Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.

Circulation. 2004 Nov 16;110(20):3281-8. Review. No abstract available.

20.

Safety of low-dose spironolactone administration in chronic haemodialysis patients.

Saudan P, Mach F, Perneger T, Schnetzler B, Stoermann C, Fumeaux Z, Rossier M, Martin PY.

Nephrol Dial Transplant. 2003 Nov;18(11):2359-63.

PMID:
14551366

Supplemental Content

Support Center